52 results
8-K
EX-10.1
RNXT
RenovoRx Inc
15 Apr 24
Unregistered Sales of Equity Securities
9:00am
shall survive the death or disability of the Purchaser and shall be binding upon and inure to the benefit of the parties and their heirs, executors
8-K
EX-10.1
RNXT
RenovoRx Inc
29 Jan 24
RenovoRx Closes $6.1 Million Private Placement
9:06am
is irrevocable by the Purchaser, except as required by applicable law, and that this Subscription Agreement shall survive the death or disability
8-K
EX-99.1
RNXT
RenovoRx Inc
29 Jan 24
RenovoRx Closes $6.1 Million Private Placement
9:06am
continues its ongoing pivotal TIGeR-PaC Phase III clinical trial, with a second interim analysis for this study to occur at the 52nd event (death
8-K
EX-3.1
l876kq
8 Sep 23
Amendments to Articles of Incorporation or Bylaws
7:41pm
424B5
2zt3ffllq
3 Apr 23
Prospectus supplement for primary offering
9:00am
8-K
EX-10.2
uym v2z3s
19 Sep 22
RenovoRx Appoints Angela Gill Nelms as Chief Operating Officer
8:45am
8-K
useru7m tr
19 Sep 22
RenovoRx Appoints Angela Gill Nelms as Chief Operating Officer
8:45am
DEF 14A
wavt8alcwep576 newy
29 Apr 22
Definitive proxy
4:06pm
10-K
EX-10.2
rwlu6
30 Mar 22
Annual report
7:21am